Association ofABCB1polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association ofABCB1polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 13, Issue 5, Pages 615-624
Publisher
Future Medicine Ltd
Online
2012-03-30
DOI
10.2217/pgs.11.176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II randomized study of the safety, efficacy, metabolism, and molecular targets of erlotinib in African Americans (AA) with NSCLC.
- (2017) M. A. Villalona-Calero et al. JOURNAL OF CLINICAL ONCOLOGY
- Erlotinib ‘dosing-to-rash’: a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer
- (2011) A C Mita et al. BRITISH JOURNAL OF CANCER
- P-Glycoprotein (ABCB1) expression in human skin is mainly restricted to dermal components
- (2011) Claudia Skazik et al. EXPERIMENTAL DERMATOLOGY
- Erlotinib at a Dose of 25 mg Daily for Non-small Cell Lung Cancers with EGFR Mutations
- (2010) Wee-Lee Yeo et al. Journal of Thoracic Oncology
- Serum Concentrations of Erlotinib at a Dose of 25 mg Daily
- (2010) Daniel B. Costa et al. Journal of Thoracic Oncology
- Very important pharmacogene summary
- (2010) Laura M. Hodges et al. Pharmacogenetics and Genomics
- A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
- (2009) King Leung Fung et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib
- (2009) C Lemos et al. BRITISH JOURNAL OF CANCER
- Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma
- (2009) Fabienne Thomas et al. EUROPEAN JOURNAL OF CANCER
- Overcoming CYP1A1/1A2 Mediated Induction of Metabolism by Escalating Erlotinib Dose in Current Smokers
- (2009) Andrew N. Hughes et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity
- (2009) Nielka P. van Erp et al. JOURNAL OF CLINICAL ONCOLOGY
- Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration
- (2009) Albert-Jan L.H.J. Aarnoudse et al. Pharmacogenetics and Genomics
- Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability
- (2008) Uroš Potočnik et al. CANCER GENETICS AND CYTOGENETICS
- ABCB1 Genetic Variation Influences the Toxicity and Clinical Outcome of Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel
- (2008) T. M. Sissung et al. CLINICAL CANCER RESEARCH
- Pharmacogenomic and Pharmacokinetic Determinants of Erlotinib Toxicity
- (2008) Charles M. Rudin et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice
- (2008) S. Marchetti et al. MOLECULAR CANCER THERAPEUTICS
- Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs
- (2008) Chin-Chuan Hung et al. Pharmacogenetics and Genomics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started